Injectable opioid agonist treatment (iOAT) is a safe and effective treatment option for individuals with severe opioid dependence. Currently, the medications used for iOAT are either not publicly funded in Ontario or are not funded at the required doses needed to be effective. Without access to these medications, an evidence-based, life saving, and cost-effective treatment is virtually unavailable to those who need it most. This snapshot focuses in on why that is and what steps are needed to fill this critical gap.
